Cisatracurium besylate injection is a nondepolarizing neuromuscular blocker indicated:
- as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric
- patients 1 month to 12 years of age
- to provide skeletal muscle relaxation during surgery in adults and in pediatric patients 2 to 12
- years of age as a bolus or infusion maintenance
- for mechanical ventilation in the ICU in adults